Oclacitinib maleate*
Therapeutic Category:
Anti-Dermatitis / Anti-Itching
Selective JAK1 inhibitor, blocks cytokine signaling involved in inflammation and
allergy response
Primary Use:
Controls itching, inflammation, and allergic/atopic dermatitis in dogs
Immunomodulator – targets allergy-related cytokines
Target Species:
Pets (dogs and cats)
Status:
Commercial
Monograph:
In House
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.